Ding Wang
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
Papers in
-
- Protein Degradation and Inhibitors 3
- RNA modifications and cancer 3
- Circular RNAs in diseases 2
- Oncology 5
- Co-authors
- Baofeng Guo (10 shared papers)Libo Xu (5 shared papers)Dhan V. Kalvakolanu (6 shared papers)Yang Li (2 shared papers)Xiaodong Wei (3 shared papers)Hongwu Zheng (3 shared papers)Hang Liang (3 shared papers)Qian Wang (3 shared papers)
- Journals
- International Journal of Oncology (2 papers)Biochemical Pharmacology (2 papers)Molecular Cancer Therapeutics (1 paper)Journal of Food Composition and Analysis (1 paper)International Journal of Medical Sciences (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Ding Wang
18 papers receiving 353 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 130
- Molecular Biology 236
- Biotechnology 24
- Oncology 59
- Genetics 22
Countries citing papers authored by Ding Wang
This map shows the geographic impact of Ding Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding Wang more than expected).
Fields of papers citing papers by Ding Wang
This network shows the impact of papers produced by Ding Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding Wang. The network helps show where Ding Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ding Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 68 | |
| 2 | 2019 | 54 | |
| 3 | 2021 | 45 | |
| 4 | 2019 | 27 | |
| 5 | 2020 | 25 | |
| 6 | 2021 | 20 | |
| 7 | 2020 | 18 | |
| 8 | 2022 | 14 | |
| 9 | 2020 | 14 | |
| 10 | 2019 | 13 | |
| 11 | 2014 | 12 | |
| 12 | 2017 | 11 | |
| 13 | 2021 | 10 | |
| 14 | 2017 | 8 | |
| 15 | 2024 | 6 | |
| 16 | 2019 | 4 | |
| 17 | 2018 | 4 | |
| 18 | 2025 | 2 | |
| 19 | Implementation of management system with longitudinal synthesized structure based on B/S and C/S modes | 2004 | 0 |
| 20 | 2025 | 0 |
About Ding Wang
Ding Wang is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Biomedical Engineering, having authored 21 papers that have together received 355 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (3 papers), Cancer-related molecular mechanisms research (3 papers), RNA modifications and cancer (3 papers), MicroRNA in disease regulation (2 papers), Nanoplatforms for cancer theranostics (2 papers), Cancer Research and Treatments (2 papers), Virus-based gene therapy research (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Cancer Research (130 citations), Molecular Biology (236 citations), Biotechnology (24 citations), Oncology (59 citations) and Genetics (22 citations). Ding Wang has collaborated with scholars based in China and United States. Frequent co-authors include Baofeng Guo, Libo Xu, Dhan V. Kalvakolanu, Yang Li, Xiaodong Wei, Hongwu Zheng, Hang Liang, Qian Wang, Zhong Chen and Xiaohui Jiang. Their work appears in journals such as International Journal of Oncology, Biochemical Pharmacology, Molecular Cancer Therapeutics, Journal of Food Composition and Analysis and International Journal of Medical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.